Device for Injecting Fluid into Eye Suprachoroidal Passage

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083589A1, detailing a device and method for injecting fluid into the suprachoroidal passage of an eye. The application, assigned to Everads Therapy Ltd., describes a device with a sharp needle and an elongated tissue separator to create a suprachoroidal passage for fluid injection. The injected fluid contains viscous agents intended to achieve short-term or long-term suprachoroidal buckling.

This publication represents a new patent application and does not impose immediate regulatory obligations on entities. However, it signals potential future developments in ophthalmic drug delivery and medical devices. Companies involved in the development or manufacturing of ophthalmic treatments, drug delivery systems, or related medical devices should be aware of this patent filing as it may impact future product development, intellectual property strategies, and market competition in the ophthalmology sector.